Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients

BACKGROUND: Rates and risk factors for cytomegalovirus (CMV) prophylaxis breakthrough and discontinuation were investigated, given uncertainty regarding optimal dosing for CMV primary (val)ganciclovir prophylaxis after solid organ transplantation (SOT). METHODS: Recipients transplanted from 2012 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurana, Mark P, Lodding, Isabelle P, Mocroft, Amanda, Sørensen, Søren S, Perch, Michael, Rasmussen, Allan, Gustafsson, Finn, Lundgren, Jens D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Editor's Choice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559280/
https://www.ncbi.nlm.nih.gov/pubmed/31211159
http://dx.doi.org/10.1093/ofid/ofz215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559280/
https://www.ncbi.nlm.nih.gov/pubmed/31211159
http://dx.doi.org/10.1093/ofid/ofz215

Ejemplares similares